Clinical trials have indicated that immunoablation followed by autologous hematopoietic
stem cell transplantation (ASCT) has the potential to induce clinical remission in patients with …

Regulatory T cells (Treg) expand during pregnancy and are present at the fetal-maternal
interface at very early stages in pregnancy. The migration mechanisms of Treg to the pregnant …

Objectives To investigate whether bortezomib, a proteasome inhibitor approved for treatment
of multiple myeloma, induces clinically relevant plasma cell (PC) depletion in patients with …

Objectives Defects in regulatory T cell (Treg) biology have been associated with human
systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). However, the …

Microorganisms and plants synthesize a diverse array of natural products, many of which
have proven indispensable to human health and well-being. Although many thousands of …

Survival of plasma cells is regulated by B-cell maturation antigen (BCMA), a membrane-bound
receptor activated by its agonist ligands BAFF and APRIL. Here we report that γ-…

Specific serum antibodies mediating humoral immunity and autoimmunity are provided by
mature plasma cells (PC) residing in the bone marrow (BM), yet their dynamics and …

Daratumumab, a human monoclonal antibody that targets CD38, depletes plasma cells and
is approved for the treatment of multiple myeloma. Long-lived plasma cells are implicated in …

Hematopoietic stem cell transplantation (HSCT) has evolved for >20 years as a specific
treatment of patients with autoimmune disease (AD). Using European Society for Blood and …

Introduction: Secondary haemophagocytic lymphohistiocytosis (sHLH) or Macrophage
Activation Syndrome (MAS) is a life-threatening hyperinflammatory syndrome that can occur in …